Emerald Announces the Launch of reMind: A New Business Resource for the Psychedelics Revolution
October 6, 2022
Ryan Allway October 6th, 2022 Psychedelics, Top News Dedicated to the advancement of breakthrough medicine and treatments in psychedelics, reMind will host its debut event — The Psychedelics Business Forum — at MJBizCon NEW YORK, October 06, 2022–(BUSINESS WIRE)–Emerald Holding, Inc. (NYSE: EEX), today introduced reMind, a new media and events platform committed... Read more
Irwin Naturals Agrees to Add Idaho Clinic to Its National Chain of Psychedelic Mental-Health Clinics
October 4, 2022
Ryan Allway October 4th, 2022 Psychedelics, Top News Irwin Naturals Emergence announces acquisition agreement in Idaho, continuing national rollup of ketamine clinics LOS ANGELES, Oct. 04, 2022 (GLOBE NEWSWIRE) — Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) has reached a binding agreement on September 30, 2022... Read more
Silo Wellness Executes Definitive Agreement to Acquire Dyscovry Science and Its Psilocybin Pharmaceutical Biosynthesis and Research Portfolio
September 27, 2022
Ryan Allway September 27th, 2022 Psychedelics, Top News Toronto, Ontario–(Newsfile Corp. – September 27, 2022) – Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K7A) (“Silo Wellness” or the “Company”), a leading global psychedelics company, and Dyscovry Science Ltd. (“Dyscovry”), a Toronto-based biotechnology company focused on biosynthetic manufacturing of... Read more
Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock
September 27, 2022
Ryan Allway September 27th, 2022 Psychedelics, Top News, Top Story Silo Pharma common stock to begin trading on Nasdaq Tuesday, September 27, 2022, under the symbol “SILO” ENGLEWOOD CLIFFS, NJ , Sept. 27, 2022 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (formerly OTCQB: SILO), a developmental stage biopharmaceutical... Read more
Wellbeing Subsidiary KGK Science Opens New Clinical Research Center to Reimagine a Healthier Future
Hemp September 26, 2022
Ryan Allway September 26th, 2022 News, Top News New Clinical Facility in London, Ontario Accelerates Research and Innovation VANCOUVER, British Columbia, September 26, 2022–(BUSINESS WIRE)–Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company“) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions,... Read more
Clearmind Applies for Patent to Treat Obesity and Metabolic Syndrome
September 22, 2022
Ryan Allway September 22nd, 2022 Psychedelics, Top News Patent Application, Based on Research at the Hebrew University, is Latest Result of Ongoing Collaboration with SciSparc Ltd. VANCOUVER, Sept. 22, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (CSE: CMND), (OTC Pink: CMNDF), (FSE: CWY0) (“Clearmind” or the “Company“), a biotech... Read more
Irwin Naturals Emergence to Add Ohio Ketamine Clinic
Ohio September 6, 2022
Ryan Allway September 6th, 2022 Psychedelics, Top News Company announces agreement that will expand its national chain of health clinics into central Ohio LOS ANGELES, Sept. 06, 2022 (GLOBE NEWSWIRE) — Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today that it has entered into a... Read more
Optimi Health Provides Progress Report On Year Of Commercialization
September 1, 2022
VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce and supply natural, EU-GMP grade psilocybin and synthetic psychedelic substances, as well as functional mushrooms that focus on the health and wellness markets, is pleased to... Read more
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Ryan Allway August 25th, 2022 Psychedelics, Top News VANCOUVER, British Columbia, Aug. 24, 2022 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), is an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders. ... Read more
